Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Ingrid Pabinger, MD, Cihan Ay, MD, Daniela Dunkler, Johannes Thaler, Eva-Maria Reitter, Christine Marosi, Christoph Zielinski, Christine Mannhalter

Blood (2012) 120 (21): 2253.

https://doi.org/10.1182/blood.V120.21.2253.2253

Published: 2012

Journal Articles

Prediction of venous thromboembolism in cancer patients

Cihan Ay, Daniela Dunkler, Christine Marosi, Alexandru-Laurentiu Chiriac, Rainer Vormittag, Ralph Simanek, Peter Quehenberger, Christoph Zielinski, Ingrid Pabinger

Blood (2010) 116 (24): 5377–5382.

https://doi.org/10.1182/blood-2010-02-270116

Published: 2010

Journal Articles

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, MD, Rainer Vormittag, MD, Daniela Dunkler, PhD, Ralph Simanek, MD, Alexandru-Laurentiu Chiriac, MD, Johannes Drach, MD, Peter Quehenberger, MD, Oswald Wagner, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2008) 112 (11): 3824.

https://doi.org/10.1182/blood.V112.11.3824.3824

Published: 2008

Journal Articles

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

Cihan Ay, Ralph Simanek, Rainer Vormittag, Daniela Dunkler, Guelay Alguel, Silvia Koder, Gabriela Kornek, Christine Marosi, Oswald Wagner, Christoph Zielinski, Ingrid Pabinger

Blood (2008) 112 (7): 2703–2708.

https://doi.org/10.1182/blood-2008-02-142422

Published: 2008

Journal Articles

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Cihan Ay, MD, Ralph Simanek, MD, Rainer Vormittag, MD, Daniela Dunkler, PhD, Guelay Alguel, MD, Silvia Koder, Oswald Wagner, MD, Christoph Zielinski, MD, Ingrid Pabinger, MD

Blood (2007) 110 (11): 701.

https://doi.org/10.1182/blood.V110.11.701.701

Published: 2007

NARROW

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Prediction of venous thromboembolism in cancer patients

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Email alerts

ASH Publications

American Society of Hematology

Factor V Leiden Mutation Increases the Risk of Venous Thromboembolism in Cancer Patients – Results From the Vienna Cancer and Thrombosis Study (CATS).

Prediction of venous thromboembolism in cancer patients

Predictive Value of D-Dimer Levels for Venous Thromboembolism in Cancer Patients: Results from the Vienna Cancer and Thrombosis Study (CATS)

High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS)

High Plasma Levels of Soluble P-Selectin Are Predictive for Venous Thromboembolism in Cancer Patients - Results from the Vienna Cancer and Thrombosis Study (CATS).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only